PubMed:14707488 / 1509-1720 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":211},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":211},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The results revealed an elevation in serum AGR-GnT-III levels in 60 of 86 patients (3.03 +/- 2.04 microg/ml) with liver cirrhosis (LC) and 86 of 91 patients (2.73 +/- 0.59 microg/ml) with chronic hepatitis (CH)."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T2","span":{"begin":114,"end":119},"obj":"http://purl.obolibrary.org/obo/MAT_0000097"}],"text":"The results revealed an elevation in serum AGR-GnT-III levels in 60 of 86 patients (3.03 +/- 2.04 microg/ml) with liver cirrhosis (LC) and 86 of 91 patients (2.73 +/- 0.59 microg/ml) with chronic hepatitis (CH)."}

{"project":"PubmedHPO","denotations":[{"id":"T3","span":{"begin":120,"end":129},"obj":"HP_0001394"}],"text":"The results revealed an elevation in serum AGR-GnT-III levels in 60 of 86 patients (3.03 +/- 2.04 microg/ml) with liver cirrhosis (LC) and 86 of 91 patients (2.73 +/- 0.59 microg/ml) with chronic hepatitis (CH)."}

{"project":"mondo_disease","denotations":[{"id":"T7","span":{"begin":114,"end":129},"obj":"Disease"},{"id":"T8","span":{"begin":131,"end":133},"obj":"Disease"},{"id":"T9","span":{"begin":188,"end":205},"obj":"Disease"},{"id":"T10","span":{"begin":207,"end":209},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005155"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005155"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"}],"text":"The results revealed an elevation in serum AGR-GnT-III levels in 60 of 86 patients (3.03 +/- 2.04 microg/ml) with liver cirrhosis (LC) and 86 of 91 patients (2.73 +/- 0.59 microg/ml) with chronic hepatitis (CH)."}

{"project":"Anatomy-MAT","denotations":[{"id":"T2","span":{"begin":114,"end":119},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"mat_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MAT_0000097"}],"text":"The results revealed an elevation in serum AGR-GnT-III levels in 60 of 86 patients (3.03 +/- 2.04 microg/ml) with liver cirrhosis (LC) and 86 of 91 patients (2.73 +/- 0.59 microg/ml) with chronic hepatitis (CH)."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T2","span":{"begin":114,"end":119},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"The results revealed an elevation in serum AGR-GnT-III levels in 60 of 86 patients (3.03 +/- 2.04 microg/ml) with liver cirrhosis (LC) and 86 of 91 patients (2.73 +/- 0.59 microg/ml) with chronic hepatitis (CH)."}

{"project":"HP-phenotype","denotations":[{"id":"T6","span":{"begin":114,"end":129},"obj":"Phenotype"},{"id":"T7","span":{"begin":131,"end":133},"obj":"Phenotype"},{"id":"T8","span":{"begin":188,"end":205},"obj":"Phenotype"},{"id":"T9","span":{"begin":207,"end":209},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"HP:0001394"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"HP:0001394"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"HP:0200123"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"HP:0200123"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"The results revealed an elevation in serum AGR-GnT-III levels in 60 of 86 patients (3.03 +/- 2.04 microg/ml) with liver cirrhosis (LC) and 86 of 91 patients (2.73 +/- 0.59 microg/ml) with chronic hepatitis (CH)."}